Next Article in Journal
Effect of Tasurgratinib as an Orally Available FGFR1–3 Inhibitor on Resistance to a CDK4/6 Inhibitor and Endocrine Therapy in ER+/HER2 Breast Cancer Preclinical Models
Next Article in Special Issue
Prognostic Value of Preoperative Hemoglobin in Patients Undergoing Radical Prostatectomy for Localized Prostate Cancer
Previous Article in Journal
Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes
Previous Article in Special Issue
Improving Risk Stratification in pT3 Upper Tract Urothelial Carcinoma: A Focus on Invasion Patterns
 
 
Article

Article Versions Notes

Cancers 2025, 17(7), 1083; https://doi.org/10.3390/cancers17071083
Action Date Notes Link
article xml file uploaded 24 March 2025 10:30 CET Original file -
article xml uploaded. 24 March 2025 10:30 CET Update https://www.mdpi.com/2072-6694/17/7/1083/xml
article pdf uploaded. 24 March 2025 10:30 CET Version of Record https://www.mdpi.com/2072-6694/17/7/1083/pdf
article html file updated 24 March 2025 10:31 CET Original file -
article html file updated 24 June 2025 21:26 CEST Update https://www.mdpi.com/2072-6694/17/7/1083/html
Back to TopTop